5JTR
 
 | | The structure of chaperone SecB in complex with unstructured MBP binding site e | | Descriptor: | Maltose-binding periplasmic protein, Protein-export protein SecB | | Authors: | Huang, C, Saio, T, Rossi, P, Kalodimos, C.G. | | Deposit date: | 2016-05-09 | | Release date: | 2016-08-24 | | Last modified: | 2024-05-15 | | Method: | SOLUTION NMR | | Cite: | Structural basis for the antifolding activity of a molecular chaperone.
Nature, 537, 2016
|
|
2D21
 | | NMR Structure of stereo-array isotope labelled (SAIL) maltodextrin-binding protein (MBP) | | Descriptor: | Maltose-binding periplasmic protein | | Authors: | Kainosho, M, Torizawa, T, Iwashita, Y, Terauchi, T, Ono, A.M, Guntert, P. | | Deposit date: | 2005-09-02 | | Release date: | 2006-03-07 | | Last modified: | 2024-05-29 | | Method: | SOLUTION NMR | | Cite: | Optimal isotope labelling for NMR protein structure determinations.
Nature, 440, 2006
|
|
2V93
 | | EQUILLIBRIUM MIXTURE OF OPEN AND PARTIALLY-CLOSED SPECIES IN THE APO STATE OF MALTODEXTRIN-BINDING PROTEIN BY PARAMAGNETIC RELAXATION ENHANCEMENT NMR | | Descriptor: | 1-(1-HYDROXY-2,2,6,6-TETRAMETHYLPIPERIDIN-4-YL)PYRROLIDINE-2,5-DIONE, MALTOSE-BINDING PERIPLASMIC PROTEIN | | Authors: | Clore, G.M, Tang, C. | | Deposit date: | 2007-08-21 | | Release date: | 2007-11-06 | | Last modified: | 2011-07-13 | | Method: | SOLUTION NMR | | Cite: | Open-to-Closed Transition in Apo Maltose-Binding Protein Observed by Paramagnetic NMR.
Nature, 449, 2007
|
|
5ZR0
 | | Solution structure of peptidyl-prolyl cis/trans isomerase domain of Trigger Factor in complex with MBP | | Descriptor: | Maltose-binding periplasmic protein,Trigger factor | | Authors: | Kawagoe, S, Nakagawa, H, Kumeta, H, Ishimori, K, Saio, T. | | Deposit date: | 2018-04-21 | | Release date: | 2018-08-22 | | Last modified: | 2024-05-01 | | Method: | SOLUTION NMR | | Cite: | Structural insight into prolinecis/transisomerization of unfolded proteins catalyzed by the trigger factor chaperone.
J. Biol. Chem., 293, 2018
|
|
2MV0
 | | Solution NMR Structure of Maltose-binding protein from Escherichia coli, Northeast Structural Genomics Consortium (NESG) Target ER690 | | Descriptor: | Maltose-binding periplasmic protein | | Authors: | Rossi, P, Lange, O.F, Sgourakis, N.G, Song, Y, Lee, H, Aramini, J.M, Ertekin, A, Xiao, R, Acton, T.B, Baker, D, Montelione, G.T, Northeast Structural Genomics Consortium (NESG) | | Deposit date: | 2014-09-18 | | Release date: | 2014-12-10 | | Last modified: | 2024-05-15 | | Method: | SOLUTION NMR | | Cite: | Determination of solution structures of proteins up to 40 kDa using CS-Rosetta with sparse NMR data from deuterated samples.
Proc.Natl.Acad.Sci.USA, 109, 2012
|
|
2N45
 | | EC-NMR Structure of Escherichia coli Maltose-binding protein Determined by Combining Evolutionary Couplings (EC) and Sparse NMR Data with a second set of RDC data simulated for an alternative alignment tensor. Northeast Structural Genomics Consortium target ER690 | | Descriptor: | Maltose-binding periplasmic protein | | Authors: | Tang, Y, Huang, Y.J, Hopf, T.A, Sander, C, Marks, D, Montelione, G.T, Northeast Structural Genomics Consortium (NESG) | | Deposit date: | 2015-06-17 | | Release date: | 2015-07-01 | | Last modified: | 2024-05-15 | | Method: | SOLUTION NMR | | Cite: | Protein structure determination by combining sparse NMR data with evolutionary couplings.
Nat.Methods, 12, 2015
|
|
1EZO
 | | GLOBAL FOLD OF MALTODEXTRIN BINDING PROTEIN COMPLEXED WITH BETA-CYCLODEXTRIN | | Descriptor: | MALTOSE-BINDING PERIPLASMIC PROTEIN | | Authors: | Mueller, G.A, Choy, W.Y, Yang, D, Forman-Kay, J.D, Venters, R.A, Kay, L.E. | | Deposit date: | 2000-05-11 | | Release date: | 2001-05-03 | | Last modified: | 2024-05-22 | | Method: | SOLUTION NMR | | Cite: | Global folds of proteins with low densities of NOEs using residual dipolar couplings: application to the 370-residue maltodextrin-binding protein.
J.Mol.Biol., 300, 2000
|
|
1EZP
 | | GLOBAL FOLD OF MALTODEXTRIN BINDING PROTEIN COMPLEXED WITH BETA-CYCLODEXTRIN USING PEPTIDE ORIENTATIONS FROM DIPOLAR COUPLINGS | | Descriptor: | MALTODEXTRIN BINDING PERIPLASMIC PROTEIN | | Authors: | Mueller, G.A, Choy, W.Y, Yang, D, Forman-Kay, J.D, Venters, R.A, Kay, L.E. | | Deposit date: | 2000-05-11 | | Release date: | 2001-05-08 | | Last modified: | 2024-05-22 | | Method: | SOLUTION NMR | | Cite: | Global folds of proteins with low densities of NOEs using residual dipolar couplings: application to the 370-residue maltodextrin-binding protein.
J.Mol.Biol., 300, 2000
|
|
6OVC
 | | hMcl1 inhibitor complex | | Descriptor: | (2S)-N-(benzylsulfonyl)-4-(cyclobutylmethyl)-2-(2,4-dichlorophenyl)-3,4-dihydro-2H-1,4-benzoxazine-6-carboxamide, Induced myeloid leukemia cell differentiation protein Mcl-1 | | Authors: | Poppe, L. | | Deposit date: | 2019-05-07 | | Release date: | 2019-05-22 | | Last modified: | 2024-05-01 | | Method: | SOLUTION NMR | | Cite: | AMG 176, a Selective MCL1 Inhibitor, Is Effective in Hematologic Cancer Models Alone and in Combination with Established Therapies.
Cancer Discov, 8, 2018
|
|
2H25
 | |
2N44
 | | EC-NMR Structure of Escherichia coli Maltose-binding protein Determined by Combining Evolutionary Couplings (EC) and Sparse NMR Data. Northeast Structural Genomics Consortium target ER690 | | Descriptor: | Maltose-binding periplasmic protein | | Authors: | Tang, Y, Huang, Y.J, Hopf, T.A, Sander, C, Marks, D, Montelione, G.T, Northeast Structural Genomics Consortium (NESG) | | Deposit date: | 2015-06-16 | | Release date: | 2015-07-01 | | Last modified: | 2024-05-15 | | Method: | SOLUTION NMR | | Cite: | Protein structure determination by combining sparse NMR data with evolutionary couplings.
Nat.Methods, 12, 2015
|
|
2MHS
 | | NMR Structure of human Mcl-1 | | Descriptor: | Induced myeloid leukemia cell differentiation protein Mcl-1 | | Authors: | Liu, G, Poppe, L, Aoki, K, Yamane, H, Lewis, J, Szyperski, T. | | Deposit date: | 2013-12-04 | | Release date: | 2014-05-14 | | Last modified: | 2024-05-15 | | Method: | SOLUTION NMR | | Cite: | High-Quality NMR Structure of Human Anti-Apoptotic Protein Domain Mcl-1(171-327) for Cancer Drug Design.
Plos One, 9, 2014
|
|
